BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19027781)

  • 1. Human ether-a-go-go related gene (hERG) K+ channels: function and dysfunction.
    Perrin MJ; Subbiah RN; Vandenberg JI; Hill AP
    Prog Biophys Mol Biol; 2008; 98(2-3):137-48. PubMed ID: 19027781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HERG K+ channel, the target of anti-arrhythmias drugs].
    Guan FY; Yang SJ
    Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hERG potassium channels and cardiac arrhythmia.
    Sanguinetti MC; Tristani-Firouzi M
    Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in research on defective protein trafficking and functional restoration in HERG-associated long QT syndrome].
    Fang P; Lian J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):101-4. PubMed ID: 26829745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2.
    Han SN; Yang SH; Zhang Y; Sun XY; Duan YY; Hu XJ; Fan TL; Huang CZ; Yang G; Zhang Z; Zhang L
    Int J Mol Med; 2014 Sep; 34(3):810-5. PubMed ID: 24993425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HERG trafficking and pharmacological rescue of LQTS-2 mutant channels.
    Robertson GA; January CT
    Handb Exp Pharmacol; 2006; (171):349-55. PubMed ID: 16610352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
    Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
    Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
    Guo J; Gang H; Zhang S
    J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
    Gianulis EC; Trudeau MC
    J Biol Chem; 2011 Jun; 286(25):22160-9. PubMed ID: 21536673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired QT interval prolongation and HERG: implications for drug discovery and development.
    Finlayson K; Witchel HJ; McCulloch J; Sharkey J
    Eur J Pharmacol; 2004 Oct; 500(1-3):129-42. PubMed ID: 15464027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse ERG K(+) channel clones reveal differences in protein trafficking and function.
    Lin EC; Moungey BM; Lim E; Concannon SP; Anderson CL; Kyle JW; Makielski JC; Balijepalli SY; January CT
    J Am Heart Assoc; 2014 Dec; 3(6):e001491. PubMed ID: 25497881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes.
    Mehta A; Sequiera GL; Ramachandra CJ; Sudibyo Y; Chung Y; Sheng J; Wong KY; Tan TH; Wong P; Liew R; Shim W
    Cardiovasc Res; 2014 Jun; 102(3):497-506. PubMed ID: 24623279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome.
    Johnson WH; Yang P; Yang T; Lau YR; Mostella BA; Wolff DJ; Roden DM; Benson DW
    Pediatr Res; 2003 May; 53(5):744-8. PubMed ID: 12621127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data.
    Jonker DM; Kenna LA; Leishman D; Wallis R; Milligan PA; Jonsson EN
    Clin Pharmacol Ther; 2005 Jun; 77(6):572-82. PubMed ID: 15961988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hERG K(+) channels: structure, function, and clinical significance.
    Vandenberg JI; Perry MD; Perrin MJ; Mann SA; Ke Y; Hill AP
    Physiol Rev; 2012 Jul; 92(3):1393-478. PubMed ID: 22988594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
    Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
    Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
    Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG.
    Hayashi K; Shimizu M; Ino H; Yamaguchi M; Terai H; Hoshi N; Higashida H; Terashima N; Uno Y; Kanaya H; Mabuchi H
    Clin Sci (Lond); 2004 Aug; 107(2):175-82. PubMed ID: 15043509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.